Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces Results from Clinical Study Including Real Scientific Hemp Oil-X™ (RSHO-X™) on Patients with Tuberous Sclerosis Complex (TSC)

Here’s the intro

More at

The study targeted the reduction in frequency, intensity and duration of convulsive crises in people with tuberous sclerosis complex (TSC) and saw promising results from cannabidiol (CBD) as a treatment for patients with TSC. Other factors observed in the study were quality of life, dependence on heavy prescription drugs and long-term sustainability of treatment with CBD.

The trial was comprised of patients with varying forms of epilepsy, with the majority having TSC, a genetic disorder characterized by the growth of noncancerous (benign tumors) in many parts of the body, including the brain, which can lead to convulsive crises. TSC affects 1 million people worldwide, 50,000 in the U.S. and 20,000 in Mexico.

Primary Sponsors

Karma Koala Podcast

Top Marijuana Blog